Stocks In News - Expansion

1. Bal Pharma has commencement of commercial production at Udaipur unit.
2. The company informed exchanges that after obtaining all the regulatory approvals, its bulk drugs manufacturing unit at Udaipur has commenced commercial production of intermediates and active pharma ingredients (API).
3. The API products which of scheduled to be manufactured at this Unit were developed by R&D facility at Bangalore and due to capacity constraints at Bangalore facility they could not become commercially viable till now.
4. This unit is expected to ease the capacity concerns of API's and intermediates and will cater to the North are Northeastern markets of the country and also overseas markets.